|
Scientific Publications
| Publications |
| |
Etzkorn KP, Diab F, Rashid A, Dodda S, Brown RD, Venu RP. Endoscopic retrograde cholangiopancreatography under general anesthesia; Indications and results. Gastrointestinal Endoscopy 47(5)363-367,1998 |
|
Etzkorn KP, Vitello J, McGuire DE, Resruck D, Venu RP, Watkins JL. A new technique for jejunal tube placement: A marriage of enteroscope and laparoscope. Gastrointestinal Endoscopy 43(6): 610-614, 1996. |
|
Etzkorn KP, Venu RP, Brown RD, McGuire DE, Abu-Hammour A. Saline injection needle knife sphincterotomy: A preliminary report. Endoscopy 28:360-364, 1996. |
|
Glaws WR, Etzkorn KP, Wenig BL, Zulfiqar H, Wiley TE, Watkins JL. Comparison of rigid and flexible esophagoscopy in the diagnosis of esophageal disease: Diagnostic accuracy, complications, and cost. Annals of Otology Rhinology Laryngology 105:262-265, 1996 |
|
Watkins JL, Etzkorn KP, Wiley TE, DeGuzman LJ, Harig JM. Assessment of technical competence during ERCP training. Gastrointestinal Endoscopy 44(4) 411-415. 1996.
|
|
McGuire, DE, Venu RP, Brown, RD, Etzkorn, KP, Glaws RW, Abu-Hammour A. Brush cytology for pancreatic carcinoma: An analysis of factors influencing results. Gastrointestinal Endoscopy 44(3) 300-304, 1996. |
|
Abu-Hammour A, Venu RP, Etzkorn KP, Shawel JL, Zaytsev PM, Brown RD. Common bile duct obstruction caused by multiple myeloma of the pancreas. Gastrointestinal Endoscopy 44(5) 606-608, 1996. |
|
Etzkorn KP, Brown RD, Mihalov M, Bavishi D. Acute colitis as complications of extracorporeal shock wave lithotripsy of renal calculi. Gastrointestinal Endoscopy (letter) 44(4) 511-512, 1996. |
|
Etzkorn, KP, DeGuzman LD, Holderman WH, Abu-Hammour A, Schlesinger PK, Harig JM, Watkins JL. Endoscopic drainage of pancreatic pseudocysts: Patient selection and evaluation of outcome by endoscopic ultrasonography. Endoscopy 27:329-33, 1995 |
|
Holderman WH, Etzkorn KP, Harig JM, Watkins JL. Endoscopic retrograde cholangiopancreatography and stent placement via gastrostomy: Technical aspects and clinical application. Endoscopy 27(1) 135-137, 1995.
|
|
Holderman, WH, Etzkorn KP, Patel SA, Harig JM, Watkins JL. Endoscopic findings and complications associated with esophageal variceal ligation. Journal Clinical Gastroenterology 21(2) 91-94, 1995. |
|
Etzkorn KP, McGuire DE, Brown RD, Venu RP. Retrograde migration of PEG tubes. Gastrointestinal Endoscopy (Letter) 42(3) 279-280, 1995. |
|
Venu RP, Abu-Hammour A, Etzkorn KP, Loguidice JA. Sphincter of Oddi in health and disease. Revista De Gastrenterolgia De Mexico 59(2) 157-164, 1994. |
|
Abu-Hammour A, Venu RP, Etzkorn KP, McGuire DE, Brown RD, Watkins JL. Bile-alkaline phosphatase activity in cholestatic disorders. Gastroenterology (Submitted). |
|
|
| Research Funding |
|
TMC435-TiDP16-C205: A Phase IIb, randomized, double-blind, placebo-controlled trial to investigate the efficacy, tolerability, safety and pharmacokinetics of TMC435 as part of a treatment regimen including peginterferon alfa-2a and ribavirin in treatment-naïve genotype 1 hepatitis C infected subjects. 2009-ongoing
|
|
A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys ®) and Ribavirin (Copegus ®) in Treatment Naïve Subjects with Genotype 1 Chronic Hepatitis C. Principal Investigator. 2008- Ongoing |
|
"Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as Measured by Sustained Virological Response) and Safety of 360 mg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kg" Sub- Investigator. 2007- Ongoing |
|
"A phase II Rollover Protocol of Telaprivir (VX-950) in Combination with Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Subjects Enrolled in the Control Group (Group A) of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Who did not Achieve or Maintain an Undetectable HCV RNA Level Through Sustained Viral Response" 2007-Ongoing |
|
"A Phase II, Randomized, Adaptive Design, Multicenter, Parallel Group, Placebo-controlled Dose-ranging Study of ATI 7505 in Patients with Postprandial Distress Syndrome" Sub- Investigator. 2007- Ongoing |
|
Comparison of Weight-based Doses of Taribavirin Combined with Peginterferon Alfa-2b Versus Ribavirin Combined with Peginterferon Alfa-2b in Therapy-naïve Patients With Chronic Hepatitis C Virus Genotype 1 Infection, Principal Investigator. 2007- Ongoing |
|
"A 52 Week, Randomized, Double-blind, Double-dummy, Placebo-controlled Study to Assess the Safety and Efficacy of a 12 Week Treatment of Acute Diverticulitis With Asacol® 2.4 g/day (400 mg Mesalamine Tablet), Followed by a 9 Month Treatment-free Observation Period" Sub- Investigator. 2007- Ongoing |
|
Psychometric Evaluation of the Nocturnal Gastroesphageal Reflux Disease Questionnaire” 2007 |
|
"A Phase 2 Study of Telaprevir (VX-950) in Combination with Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Subjects with Genotype 1 Hepatitis C Who Have Not Achieved Sustained Viral Response with a Prior Course of Interferon-Based Therapy" Principal Investigator. 2007- Ongoing |
|
Phase 3 Randomized, Double-Blinded, Placebo-Controlled Multicenter Retreatment Study of Sargramaostim (Leukine) in Patients with Active Crohn's Disease and Prior Treatment Response to Sargramostim Sub- Investigator. 2007- Ongoing |
|
Comparison of Weight-based Doses of Taribavirin Combined with Peginterferon Alfa-2b Versus Ribavirin Combined with Peginterferon Alfa-2b in Therapy-naïve Patients With Chronic Hepatitis C Virus Genotype 1 Infection. Principal Investigator, 2007- Ongoing |
|
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Study Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, with Concomitant Corticosteroids, in Steroid-Refractory Ulcerative Colitis, Principal Investigator. 2007- Ongoing |
|
Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as Measured by Sustained Virological Response) and Safety of 360 mg Induction Dosing of Pegasys in Combination with Higher Copegus Doses in Treatment-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Baseline Body Weight Greater than or Equal to 85 kg , Sub-Investigator. 2007- Ongoing |
|
A Phase 2 Study of Telaprevir (VX-950) in Combination with Peginterferon Alfa-2a (Pegasys®), and Ribavirin (Copegus®) in Subjects with Genotype 1 Hepatitis C Who Have Not Achieved Sustained Viral Response with a Prior Course of Interferon-Based Therapy” Principal Investigator. 2007 |
|
A multicenter, Open label, Treatment extension trial to evaluate the Long-Term safety and tolerability of Mesalamine Pellet formulation, Sub- Investigator. 2006-2007 |
|
A Multicenter, Randomized, Double-Blind, Actively controlled trial to evaluate the safety and efficacy of a new tablet formulation and dosing regimen of Balsalazide Disodium 3.3G Bid Versus Mesalamine ( 5-ASA) As Asacol®0.8G Tid in Mildly to Moderately Active Ulcerative Colitis, Sub- Investigator. 2006-2007 |
|
A Phase 3 open label, Single arm study to assess the safety of Aquavan® (Fospropofol Disodium) Injection for minimal to moderate sedation in patients undergoing minor surgical procedures, Principal Investigator. 2006-2007 |
|
A Phase II, Multicenter, Randomized, Double-Blind, Placebo–Controlled Study to Assess the Efficacy and Safety of Three Different Doses (275, 550, and 1100 mg) of Rifaximin Administered BID for Either Two or Four Weeks in the Treatment of Patients with Diarrhea-Associated Irritable Bowel Syndrome, Principal Investigator 2006 |
|
A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease Sub-Investigator 2006-2007 |
|
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study TO Assess the efficacy and safety of three different doses (275, 550 and1100 mg) Of Rifaximin administered bid for either Two or Four weeks in the Treatment of Patients with Diarrhea-Associated Irritable Bowel Syndrome, Principal Investigator. 2005-2008 |
|
A Phase III, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects with Active Ulcerative Colitis, Principal Investigator 2005-2007. |
|
A Phase III, Multi-Center, Open-Label, Extension Study of the Safety and Efficacy of 25 mg or 50 mg of OPC-6535 Oral Tablets in the Treatment of Subjects with Ulcerative Colitis, Principal Investigator 2005-2007. |
|
A Phase III Multi-National, Multi-Center, Open Label, 52 Week Safety Study to Assess the Safety of Chronic Therapy with the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc (Dosed 4 Weekly to Week 48), in the Treatment of Patients with Active Crohn’s Disease Who Have Previously Completed Studies CDP870-031 or CDP870-032 Principal Investigator 2005-ongoing. |
|
308180 Phase III Randomized, Double-Blind, Placebo-Controlled Multicenter Retreatment Study of Sargramostim (Luekine) in Patients with Active Crohn’s Disease and Prior Treatment Response to Sargramostim, Sub-Investigator 2005-2007. |
|
CL-C002-00 “Randomized, Double-Blind, Multi-Center, Dose Response, Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients with Moderately Active Crohn’s Disease, Sub-Investigator 2005-2007. |
|
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5 QD to Maintain Remission From Mild to Moderate Ulcerative Colitis, Sub-Investigator 2005-2007. |
|
A Phase III, Multicenter, Randomized, Double-Blind, Parallel-Arm, 52 Week Dose Comparison Study of the Efficacy and Safety of 25 mg QD of OPC-6535 Oral Tablets and 800 mg BID of Asacol in the Maintenance of Remission in Subjects with Ulcerative Colitis, Principal Investigator 2005-2007 |
|
A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate the Long-term Safety and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease, Sub-Investigator. 2004-2008 |
|
Protocol C0379T07: A Multicenter, Randomized, Blinded, Placebo-controlled, Phase IIa Study of Human Monoclonal Antibody to Anti-IL-12p40 (CNTO 1275) in Subjects With Crohn's Disease Inadequately Controlled by 5-Aminosalicylates and/or Corticosteroids, and Open-label Administration in Subjects Who are Nonresponders to Anti-TNFa Therapy Sub-Investigator 2004-2007 |
|
Protocol NV17318: Randomized, Multicenter, Double-blind, Phase IV Pilot Study Evaluating the Effect of PEGASYS® doses of 180 μg or 270 μg in Combination with Copegus® doses of 1200 mg or 1600 mg on Viral Kinetics, Virological Response, Pharmacokinetics, and Safety in Interferon-naïve Patients with Chronic Hepatitis C Genotype 1 Virus Infection of High Viral Titer and Body Weight Greater than 85 kg, Principal Investigator 2004-2006 |
|
A Multicenter, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75mg and 125mg) Administered Once Daily by Subcutaneous Infection for the Treatment of Active Ulcerative Colitis. 2004 |
|
A Phase lll, Internationally, Multicenter, Double-Blind, Placebo-Controlled Study of the Safety Efficacy and Tolerability of Intravenous Andregen TM (Natalizumab)(300mg monthly) in Maintaining Clinical Response and Remission in Subjects with Crohn’s Disease 2004 |
|
A Phase lll, Double Masked, Placebo-Controlled Study of Alicaforsen (Isis 2302, an Antisene Inhibitor of ICAM-1, for the Treatment of Patients with Active Crohn’s Disease 2004 |
|
A Phase lll, Internationally, Multicenter, Double-Blind, Placebo-Controlled Study of the Safety Efficacy and Tolerability of Intravenous Andregen TM (Natalizumab) in Subjects with Moderately to Severely Active Crohn’s Disease 2004 |
|
A 12-Week, Dose-Ranging, Double-Blind, Placebo-Controlled Study of Alosetron (GR68755) in Subjects with Irritable Bowel Syndrome 2004 |
|
A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study of Alosetron (GR68755) in Female Subjects with Irritable Bowel Syndrome, Glaxo Wellcome, Inc. 2004 |
|
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Moderate to Severe Crohn's Disease who Have Lost Response or are Intolerant to Infliximab, Sub-Investigator 2002 |
|
A Randomized, Open-labeled, Multicenter, Efficacy and Safety Study Examining the Effects of Duration of Treatment and of a High Induction Dose of PEGASYS® in Combination with Daily COPEGUS® in Patients with Chronic Hepatitis C who Did Not Respond to Previous Peginterferon alfa-2b/Ribavirin, Principal Investigator 2003-2007 |
|
Novartis Pharmaceuticals trial entitled: A 6-week randomized, double-blind, double-dummy placebo-controlled, multicenter study to assess the effect of tegaserod 2 mg t.i.d. and 6 mg t.i.d., on dyspeptic symptoms in diabetic patients with symptoms of diabetic gastropathy, Principal Investigator 2003-2005 |
|
CDP870-033 – A Phase III multi-national, multi-centre, open label, 52 week safety study to assess the safety of chronic therapy with the humanized anti-TNF PEG conjugate CDP870 400 mg sc, (dosed 4 -weekly to Week 48), in the treatment of patients with active Crohn’s disease who have previously completed studies CDP870-031 or CDP870-032, Sub-Investigator 2003 |
|
CDP870-034 – A Phase III multi-national, multi-centre, open-label, 52 week safety study to assess the safety of re-exposure after a variable interval and subsequent chronic therapy with the humanized anti-TNF PEG conjugate, Sub-Investigator 2003 |
|
CDP870 400 mg sc, (dosed at weeks 0, 2 and 4 then 4-weekly to Week 48), in the treatment of patients with active Crohn’s disease who have previously been withdrawn from studies CDP870-031 or CDP870-032 due to an exacerbation of Crohn’s disease, Sub-Investigator 2003 |
|
CDP870-034 - A Phase III multi-national, multi-centre, open-label, 52 week safety study to assess the safety of re-exposure after a variable interval and subsequent chronic therapy with the humanized anti-TNF PEG conjugate CDP870 400 mg sc, (dosed at weeks 0, 2 and 4 then 4-weekly to Week 48), in the treatment of patients with active Crohn's disease who have previously been withdrawn from studies CDP870-031 or CDP870-032 due to an exacerbation of Crohn's disease, Sub- Investigator. 2003 |
|
CDP870-031 - A Phase III multi-national, multi-centre, double-blind placebo-controlled parallel group, 26 week study to assess the safety and efficacy of the humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed at Weeks 0, 2, 4 then 4-weekly to Week 24), in the treatment of patients with active Crohn's Disease, Sub-Investigator 2003 |
|
Protocol NV17317: "Randomized, Multicenter, Open Label, Phase IV Study Evaluating the Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS® in Combination with Copegus® in Interferon-naïve Patients with Chronic Hepatitis C Genotype 2 or 3 Virus Infection, Principal Investigator 2003-2006 |
|
Phase 3 Double-Masked, Placebo-Controlled Study of Alicaforsen (ISIS 2302), an Antisense Inhibitor of ICAM-1, for the Treatment of Patients with Active Crohn's Disease, Sub-Investigator 2002 |
|
OP-2000 Incara Pharmaceutical, LMH Ulcerative Colitis Study. PI, Borland Groover Completed 2002 |
|
S-2413011 Solvay Pharmaceutical, Diarrhea-IBS predominant Study. PI, Borland-Groover Clinic. Active 2002 |
|
Rebetol (Ribavirin) Hepatitis C treatment protocol in conjunction with the California Pacific Medical Center. Schering Pharmaceuticals PI. Borland-Groover Clinic Completed 1999 |
|
M95-282 TAP Holdings, Inc., H.Pylori/Lansoprazole. Sub-PI. University of Illinois. Completed 1995 |
|
M94-177 Abbott Laboratories – Duodenal Ulcer Study. Principal Investigator. University of Illinois. Completed 1995 |
|
New Direct PEJ Placement System. Funding Corpac. Principal Investigator University of Illinois. Completed 1994 |
|
Alpha-interferon therapy for C.A.H. and incidents of psychiatric phenomenon and attempts to prevent discontinuation of therapy with psychotherapeutic intervention. Funding from Schering Pharmaceuticals. University of Illinois, Principal Investigator. Completed 1994 |
|
|
| Book Chapters |
|
Constipation Etzkorn KP, Rodriguez L. Conn’s Current Therapy 54th-2002 edition 18-20,W.B. Saunders |
|
|
| Review Articles and Non-Peer Reviewed Publications |
|
Etzkorn,K.P. What’s Hot in Gastroenterological Technology Jacksonville Medicine 53(6)209-213,2002
|
|
Etzkorn, K.P. Book Review of: Gastroenterologic Endoscopy. Gastrointestinal Endoscopy 53(2)272-274,2001 |
|
McGuire DE, Venu RP, Abu-Hammour A, Etzkorn KP, Brown RD. Periampullary disorders: A review of pathophysiology. The Gastroenterologist 3:20-27, 1995. |
|
Glaws WR, Etzkorn KP, DeGuzman LJ, Steiner S, Bernardo D, Resnick DJ, Watkins JL. Endoscopic treatment of biliary injuries associated with laparoscopic cholecystectomy: The Chicago Experience. Journal of the Chicago Medical Society 97(12) 20-25, June 21, 1994. |
|
|
| Abstracts and Poster Presentations |
|
Etzkorn KP, Petterson JM Double Balloon Enteroscopy in the Private Sector. Poster Presentation American College of Gastroenterology Scientific Meeting 2006. The American Journal of Gastroenterology A1290, S498. 101(9) 2006 |
|
Etzkorn KP, Joglekar S, Kovacevic I, Fleisher M, Maniatis A, Sack T. Collagenous Colitis in a large community based GI practice: Frequency, Workup, Treatment and Cost. Poster Presentation American College of Gastroenterology Scientific Meeting 2002 |
|
Etzkorn KP, Kovacevic I, Joglekar S, Joseph B, Hoffman J, Carter M, Fleisher M. A Continuum of the aspiration technique in biliary type 3 sphincter of oddi manometry patients and the incidence of pancreatitis. Poster Presentation DDW 2002 |
|
Fleisher M, Rubin SD, Levine AE, Burnes A, Etzkorn KP, Turner R, Hopkins K. Infliximab in the treatment of steroid-naïve ulcerative colitis. Poster Presentation 66th Annual Scientific Meeting, American College of Gastroenterology, 2001. The American Journal of Gastroenterology A925, AJG 2001 |
|
Fleisher M, Rubin SD, Levine AE, Burnes A, Etzkorn KP, Turner R, Hopkins K. Infliximab in the treatment of Crohn’s disease: Is it a steroid sparing agent or a steroid replacing agent?. Poster Presentation Presentation 66th Annual Scientific Meeting, American College of Gastroenterology, 2001. The American Journal of Gastroenterology A924, AJG 2001 |
|
Fleisher MR, Rubin SD, Sasson M, Zlatanic J, Burns A, Etzkorn KP. Remicade in the treatment of Refractory Extraintestinal Manifestations of Crohn’s Disease. Poster Presentation DDW American Gastroenterology Association 2001. Gastroenterology 3147, 2001 |
|
Diab FH, Hibbeln KP, Etzkorn KP, Brown R, Venu RP. Correlation of bile duct measurements by simultaneous ultrasound and cholangiogram. Poster Presentation at the American Gastroenterological Association, DDW 1997. Gastroenterology A503, 1997 |
|
Etzkorn KP, Watkins JL, Glaws WR, Halline AG, Bartolone CJ, Tripuraneni J, Wiley TEE, Pursell K. Evaluations of a non-endoscopic cytology balloon in the diagnosis of infectious esophageal disease in AIDS patients. Poster presentation at the American Gastroenterological Association, 1996. Gastroenterology A904, 1996 |
|
Etzkorn KP, Diab FH, McGuire DE, Brown RD, Bedford R, Yotseff P, Venu RP. ERCP under general anesthesia: Indications and results. Poster presentation, ASGE 1996. Gastrointestinal Endoscopy A84, 1996 |
|
Li SD, Etzkorn KP, Goldsein JL, Sawhney M, Licke K, Magdaroag TV. Disposable endoscopic gowns: Do they add value? Poster presentation at the ASGE, DDW 1996. Gastrointestinal Endoscopy A106, 1996 |
|
Brown RD, Venu RP, Etzkorn KP, McGuire DE, Diab FH. Yield of endopancreatic cytology for pancreatic carcinoma varies widely by anatomic region of the pancreatic duct. Poster presentation at the ASGE, DDW 1996. Gastrointestinal Endoscopy A451, 1996 |
|
Barolone CJ, Venu RP, Brown RD, Etzkorn KP, Barboi A, Carr-Locke D. Defiant pancreatic calculi: A simplified therapeutic approach. Poster presentation at the ASGE, DDW 1996. Gastrointestinal Endoscopy A448, 1996 |
|
Etzkorn KP, Venu RP, Brown RD, McGuire DE, Abu-Hammour A. Cutting the papilla closer and safer: A new technique of needle knife sphincterotomy. Poster presentation at the American Society of Gastrointestinal Endoscopy, DDW May 1995. Gastrointestinal Endoscopy A4103, 1995 |
|
Etzkorn KP, Resnick D, Vitello J, Watkins JL, McGuire DE. A new technique for jejunal feeding tube placement: A marriage of enteroscope and laparoscope. Poster presentation at the American Society of Gastrointestinal Endoscopy, DDW May 1995. Gastrointestinal Endoscopy A543, 1995 |
|
Watkins JL, Etzkorn KP, Alam I, Block KP, Goldstein JL. Incomplete colonoscopy: Incidence, causes, and further evaluation. Poster presentation at the American Society of Gastrointestinal Endoscopy, DDW May 1995. Gastrointestinal Endoscopy A364, 1995 |
|
Abu-Hammour A, Etzkorn KP, Venu RP, Brown RD, McGuire DE, Watkins JL. New criteria for ERCP prior to laparoscopic cholecystectomy in-patients with non-severe acute gallstone pancreatitis. Poster presentation at the American Society of Gastrointestinal Endoscopy, DDW, May 1995. Gastrointestinal Endoscopy A367, 1995 |
|
McGuire DE, Etzkorn KP, Hibbeln J, Aizzenstein R, Wiley TE, Owens C, Warner D, Layden TJ. A non-invasive method of determining portal hypertension: Correlation of hepatic arterial Doppler resistance values with hepatic wedge pressures and portal flow patterns in the cirrhotic liver. Poster presentation at the American Association for the Study of Liver Diseases, DDW May 1995. Gastroenterology A1120, 1995 |
|
Abu-Hammour A, Venu RP, Etzkorn KP, McGuire DE, Brown RD, Alam I, Watkins JL. Bile alkaline phosphate activity in cholestatic disorders. Poster presentation American Gastroenterological Association, DDW 1995. Gastroenterology A403, 1995 |
|
Cass OW, Freeman ML, Cohen J, Zuckerman G, Fennerty M, Randall G, Jensen D, Nord J, Cerulli M, Etzkorn KP, Edmundowicz S, Lyche K, Watkins JL, Diehl LD, Cave D, Alkawas F, Locke GR, 14 fellowship ACES study group. Acquisition of competency in endoscopic skills (ACES) during training: Early results of a multicenter study. Poster presentation at the American Society of Gastrointestinal Endoscopy, DDW May 1995. Gastrointestinal Endoscopy A88, 1995 |
|
McGuire DE, Brown RD, Venu RP, Etzkorn KP, Abu-Hammour A. Intraductal gentamicin during ERCP: Does it prevent cholangitis? Poster presentation at the American Society of Gastrointestinal Endoscopy, DDW May 19995. Gastrointestinal Endoscopy A444, 1995 |
|
Bartolone C, DeGuzman LJ, Glaws WR, Etzkorn KP, Watkins JL. GI bleeding from lung cancer metastatic to the small intestine. Poster presentation at the American College of Gastroenterology October 1994. American Journal of Gastroenterology A84, 1994 |
|
Etzkorn KP, Abu-Hammour A, DeGuzman LJ, Watkins JL. Amebic liver abscess complicated by biliary leak. Poster presentation at the American College of Gastroenterology October 1994. American Journal of Gastroenterology A454, 1994 |
|
Etzkorn KP, DeGuzman LJ, Abu-Hammour A, Harig JM, Holderman WH, Watkins JL. Endoscopic drainage of pancreatic pseudocysts: Patient selection and evaluation of outcome by endoscopic Doppler ultrasonography. Poster presentation at the American College of Gastroenterology October 1994. American Journal of Gastroenterology A150, 1994 |
|
Glaws WR, Etzkorn KP, Weinig B, Zulfigas B, Wiley TE, Watkins JL. Comparison of rigid and flexible esophagoscopy in the diagnosis of esophageal disease: Diagnostic accuracy, complications, and costs. Poster presentation at the American College of Gastroenterology October 1994. American Journal of Gastroenterology A17, 1994 |
|
DeGuzman LJ, Etzkorn KP, Watkins JL. Hemangiopericytoma: An unusual cause of obstructive jaundice. Poster presentation at the American College of Gastroenterology October 1994. American Journal of Gastroenterology A442, 1994 |
|
Glaws WR, Etzkorn KP, Watkins JL, Venu RP. “Santorinicele” occurring in a patient with pancreas divisum presenting with chronic pancreatitis. Poster presentation at the American College of Gastroenterology October 1994. American Journal of Gastroenterology A460, 1994 |
|
Etzkorn KP, Venu RP, Reedy S, Sawhney M, Brown RD, Yotseff P, Bedford R. Does general anesthesia protect against ERCP induced severe pancreatitis? Gastroenterology A388, 1996 |
|
Harvey S, Michalov M, Etzkorn KP, Sawhney M, Brown RD, Resnick D, Vitello J, Venu RP. Endoscopic cystogastrostomy and bleeding: Is there histologic evidence for a predisposition to bleed? Gastrointestinal Endoscopy A469, 1996 |
|
DeGuzman LJ, Etzkorn KP, Watkins JL. Endoscopic ultrasonography: A universal Computer database modified from the endoscopy database (formerly ASGE Database). Poster presentation, DDW May 1994. Gastroenterology A9, 1994 |
|
Abu-Hammour A, Etzkorn KP, Venu RP, Wiley TE, DeGuzman, LP, Harig JM, Watkins JL. Acute gallstone pancreatitis: New guidelines from ERCP prior to laparoscopic cholecystectomy. Poster presentation World Congress of Gastroenterology October 1994 |
|
Watkins JL, DeGuzman LJ, Wiley TE, Etzkorn KP, Harig JM. ERCP training: Assessment of procedural competence. Gastroenterology A7, 1994 |
|
Kazi S, Silas D, McGuire DE>, Etzkorn KP, Venu RP. Discordance between interpretation of ERCP films by radiologists and gastroenterologists. Gastrointestinal Endoscopy A430, 1995 |
|
|
| Presentation of Materials at National/International Meetings |
|
Etzkorn KP. Faculty Member presenting talks on : Double Balloon Enteroscopy, Sphincter of Oddi Manometry & The Difficult ERCP plus live video endoscopic demonstrations of Double Balloon Enteroscopy & ERCP. 1st Primer Curso Internacional de Endoscopia Digestiva Terapeutica, Bogota Columbia. June 23-26th 2006. |
|
Etzkorn KP. Advancements in Gastrointestinal Endoscopy. III Congreso Medico Boliviano-Americano. Sucre, Bolivia. June 21, 1997 |
|
Cass OW, Freeman ML, Cohen J, Zuckerman G, Watkins JL, Nord J, Locke GR, Jensen D, Diehl D, Cerulli M, Lyche K, Fennerty M, Edmundowicz S, Etzkorn KP, Al-Kawas F, Cave D, Lehman G, 14 fellowship ACES study group. Acquisition of competency in endoscopic skills (ACES) during training. A multicenter study. Oral and poster presentation at the ASGE DDW 1996. Gastrointestinal Endoscopy A72, 1996 |
|
Etzkorn KP, Watkins JL, Glaws WR, Halline AG, Bartolone CJ, Tripuraneni J, Wiley TE, Purcell K. Evaluation of non-endoscopic cytology balloon in the diagnosis of infectious esophageal disease in AIDS patients. American College of Gastroenterology Annual Scientific Meeting. Seattle, Washington, October 23, 1996 |
|
Glaws WR, Etzkorn KP, Wenig B, Zulfigar B, Wiley TE, Watkins JL. Comparison of rigid and flexible esophagoscopy in the diagnosis of esophageal disease: Diagnostic accuracy, complication, and costs. American Broncho-Esopahgeological Association. Palm Springs, California, May 2, 1995. |
|
Etzkorn KP, Resnick D, Vitello J, McGuire DE, Watkins JL. A new technique for jejunal feeding tube placement: A marriage of enteroscope and laparoscope, International Society of Minimally Invasive Therapeutics. Portland, Oregon, September 1995 |
|
|
Oral Presentations at CME/Educational Courses
(Local and Regional) |
|
Small Bowel Endoscopy, Double Balloon Enteroscopy. Florida SGNA Annual Meeting, Orlando Florida August 4th, 2007 |
|
Double Balloon Enteroscopy, All day lecture & live demonstration program Program Director, Baptist Medical Center and & Fuji Corporation. Feb 22, 2007 |
|
Gastrointestinal and Liver Issues in Female Patients Program Moderator Baptist Medical Center . San Jose Country Club, Jacksonville Florida February 22, 2007 |
|
Double Balloon Enteroscopy & Sphincter of Oddi Dysfunction SGNA Regional Course/ Baptist Medical Center , Jacksonville Florida. Feb 11th, 2006 |
|
New Techniques in the Work Up of Small Bowel Disease Summit at Sea Level Sponsored by St. Vincent’s Medical Center Ponte Vedra Inn & Club March 5, 2005 |
|
Heme + Patient, New GERD Treatments, & H.Pylori Quarterly Grand Rounds Dept. of Family Practice Baptist Health Care February 10th, 2005 |
|
Colon Cancer 2005 American Cancer Society Jacksonville Florida Annual Board Meeting San Jose Country Club. January 18th, 2005 |
|
Updates in Gastroenterology for Primary Care Program Director. Sponsored by Baptist Medical Center. October 27th, 2004 |
|
Nausea & Vomiting in Diabetics: New Ideas for Pharmacotherapy. At “GI Hot Topics” Sponsored by St. Vincent’s Medical Center. June 22, 2004 |
|
Advancement in ERCP: Stents, SOD Manometry, Pseudocysts. Annual Tri-State SGNA Meeting October 12,2002 Biloxi Mississippi.
|
|
New Technologies in Gastroenterology. At “GI Hot Topics 2002” Sponsored by St. Vincent’s Medical Center and Borland-Groover Clinic. March 12th, 2002 |
|
Gastroenterology in Women’s Health. OB/GYN Grand Rounds. Department of Obstetrics and Gynecology. Baptist Medical Center. Jacksonville Florida. March 4th, 2002 |
|
Medical Treatment of Acute & Chronic Pancreatitis. Fall Meeting of the Florida Society of Health-System Pharmacists. University of North Florida, Jacksonville, Florida. November 9th, 2001 |
|
Updates In Gastroenterology & Hepatology. Orange Park Community Hospital Family Practice Grand Rounds. Orange Park, Florida, October 16th, 2001 |
|
Advanced Therapeutics in the Community Setting. Focus on Access & Endoscopic Ultrasound Update Wilson-Cook Symposium & The University of Florida. Hilton Walt Disney World, Lake Buena Vista, Florida April 21, 2001 |
|
Therapeutic Endoscopy and the role of MRCP & Virtual Colonoscopy. Jacksonville Filipino Medical Society. Jacksonville Florida February 9th, 2001 |
|
HIV & HCV Co Infection Annual HIV/AIDS Statewide Conference. University of Florida Health Science Center/Jacksonville, Department of Pediatrics. October 20th, 2000 |
|
Hepatitis C in The Psychiatric Patient Population. North Florida State Hospital Noon Conference. Mcclenny Florida. August 16th, 2000 |
|
Colon Cancer – 2000, Div. Of Family Practice Noon Conference. St. Vincent’s Family Practice Residency Program. St. Vincent's Hospital, Jacksonville, Florida, May 31st, 2000 |
|
Course Director: Updates in Gastroenterology/Hepatology for the Primary Care Physician & Hands on Flexible Sigmoidoscopy Workshop. BGC Clinic & George Town University Department of Continuing Medical Education. Hilton Towers and Hotel, Jacksonville, Florida April 29th, 2000 |
|
"Colorectal Cancer & Women": Annual ALL THAT JAZZ Updates in OB-GYN. Omni Hotel, Jacksonville, Florida. November 1999 |
|
"Irritable Bowel Syndrome in 1999” Dept. of Family Practice Noon Conference. St. Vincent’s Family Practice Residency. Oct.19th,1999 |
|
“Hep C Talk”. Presented to the Florida Association of Health Maintenance organizations. University Club, Jacksonville, Florida. June 24, 1999 |
|
GI Hot Topics for Primary Care: St. Vincent’s Medical Center at Epping Forest Yacht Club, June 29, 1999 |
|
H. Pylori, & GERD Update: 23rd Annual CME Conference of the Georgia Association of Physician Assistants. Jekyll Island, Georgia. Oct 1998 |
|
Advancement in Endoscopy: Baptist-Beaches Hospital, Jacksonville Beach, Florida. CME Meeting. February 12, 1997 |
|
Advancements In Endoscopy: Utility or Futility – Department of Internal Medicine, Baptist Medical Center, Jacksonville, FL, August 1996 |
|
Irritable Bowel Syndrome: Presented at Medicine Lecture Series, Baptist Medical Center, Jacksonville, Florida. November 19, 1996 |
|
HIV and Dysphagia – Department of Family Practice, January 3, 1995. University of Illinois at Chicago |
|
Colorectal Screening in Women – Department of Obstetrics and Gynecology, September 27, 1995,University of Illinois at Chicago |
|
Endoscopic Ultrasound: Today and the Future. GI Grand Rounds – Chicago Medical School, May, 1995 |
|
Management of Cholangitis: Presented at “Updates in Gastroenterology for Primary Care Physicians”, September 15, 1995. Sponsored by Trinity Medical Center, Moline, Illinois |
|
Update in the Management of Pseudocysts: Presented at “updates in Gastroenterology: 1995”, February 8, 1995. Chicago Hyatt – Sponsored by University of Illinois Hospital |
|
Complications of ERCP: Pancreatitis and Cholangitis. Presented at a live video conference: Advanced Therapeutic Pancreaticobiliary Endoscopy and Endoscopic Ultrasonography, March 24-25, 1995. Chicago Marriott – Sponsored by the University of Illinois at Chicago |
|
|
| Mass Media Productions |
|
"Get Tested" (Producer) Public Service Announcement Video BGC & Channel 12. Jacksonville, Florida, Spring 1999 |
|
"Colon Cancer Testing" (Producer) Public Service Announcement Video, BGC & Channel 4. Jacksonville Florida, Spring 1999 |
|
"GERD & You" (Producer) Public Service Announcement Video, BGC & Channel 12. Jacksonville, Florida, Spring 1999 |
|
|
| Web Sites |
|
Borland-Groover Clinic |
|
My Best Care |
|
